Paul Krauthauser has been appointed senior vice president of sales and marketing at Rising Pharmaceuticals, a subsidiary of ACETO Corp., and Sherri Leonard has been named vice president of Portfolio Strategy.
 
Mr. Krauthauser has 17 years of experience in the pharma industry, with a focus on product marketing and sales. Most recently, he served as director of National Accounts at Sandoz Inc., a division of Novartis Group. Prior to that, he held various roles at Apotex and Teva Pharmaceuticals.
 
Ms. Leonard has worked in the pharma industry for more than 25 years and has significant experience in portfolio strategy, project management, business development, R&D, and regulatory affairs. Previously she served as vice president of business development and portfolio management at Orchidpharma, Inc. She also served as senior director of Global Implementation Lead at Pfizer and held positions with CorePharma, Endo Pharmaceuticals and Watson Pharmaceuticals. 
 
Sal Guccione, chief executive officer of ACETO, said, “We are excited to be adding Paul and Sherri to ACETO and the Rising Pharmaceuticals team. They bring with them experience and knowledge which will enhance the Company’s ability to capitalize on the significant opportunities that exist in the market for generic drugs. In a short period of time as president and chief operating officer of Rising Pharmaceuticals, Satish Srinivasan has done an excellent job bringing on highly skilled, experienced people. We look forward to the contributions that Paul and Sherri will bring to ACETO as we continue to focus on expanding our generic drug business.”